Literature DB >> 26714580

The mucosa-kidney axis in IgA nephropathy.

Jürgen Floege1, John Feehally2.   

Abstract

Links between IgA nephropathy (IgAN) and the mucosa have been recognized since the 1970s. In particular, the observation of visible haematuria induced by respiratory infections in patients with IgAN and the association of IgAN with diseases in which the mucosa plays a part, especially coeliac disease, have been taken as evidence of a mucosa-kidney axis. Here, we review current evidence that links the mucosa, in particular the gastrointestinal mucosa, and IgA produced by the bone marrow with IgAN. Genome-wide association studies in patients with IgAN have identified risk loci in genes involved in the intestinal mucosal integrity and immune network. Furthermore, the systemic immune response to mucosal antigens in IgAN is increased. Moreover, patients with IgAN have an increased reactivity to dietary proteins associated with subclinical intestinal mucosal inflammation. Associations between IgAN and gastrointestinal diseases have also been reported in a small number of patients, but whether these diseases share a common pathogenesis or whether gastrointestinal inflammation exacerbates IgAN is uncertain. Indeed, mucosal alterations such as infections could activate the innate immune system, aggravate a pre-existing IgAN and promote disease manifestations such as macrohaematuria. Various clinical interventions and trials targeting the mucosa or presumed mucosa-associated mechanisms have so far not yielded consistent findings and the results of ongoing trials are eagerly awaited.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26714580     DOI: 10.1038/nrneph.2015.208

Source DB:  PubMed          Journal:  Nat Rev Nephrol        ISSN: 1759-5061            Impact factor:   28.314


  85 in total

1.  Celiac disease and HLA DQ in patients with IgA nephropathy.

Authors:  Pekka Collin; Jaana Syrjänen; Jukka Partanen; Amos Pasternack; Katri Kaukinen; Jukka Mustonen
Journal:  Am J Gastroenterol       Date:  2002-10       Impact factor: 10.864

2.  Sequential measurements of intestinal permeability to [51Cr]EDTA in children with Henoch-Schönlein purpura nephritis.

Authors:  J C Davin; P R Mahieu
Journal:  Nephron       Date:  1992       Impact factor: 2.847

Review 3.  The bilateral responsiveness between intestinal microbes and IgA.

Authors:  Andrew J Macpherson; Yasmin Köller; Kathy D McCoy
Journal:  Trends Immunol       Date:  2015-07-11       Impact factor: 16.687

4.  Increased intestinal intra-epithelial T lymphocytes in primary glomerulonephritis: a role of oral tolerance breakdown in the pathophysiology of human primary glomerulonephritides?

Authors:  G Rostoker; J C Delchier; M T Chaumette
Journal:  Nephrol Dial Transplant       Date:  2001-03       Impact factor: 5.992

5.  Immunoglobulin A subclass-containing plasma cells in the jejunum in primary IgA nephropathy and in Henoch-Schönlein purpura.

Authors:  R J Hené; H J Schuurman; L Kater
Journal:  Nephron       Date:  1988       Impact factor: 2.847

6.  IgA nephropathy in cystic fibrosis.

Authors:  G Stirati; M Antonelli; C Fofi; S Fierimonte; G Pecci
Journal:  J Nephrol       Date:  1999 Jan-Feb       Impact factor: 3.902

7.  Interactions among secretory immunoglobulin A, CD71, and transglutaminase-2 affect permeability of intestinal epithelial cells to gliadin peptides.

Authors:  Corinne Lebreton; Sandrine Ménard; Juliette Abed; Ivan Cruz Moura; Rosanna Coppo; Christophe Dugave; Renato C Monteiro; Aurélie Fricot; Meriem Garfa Traore; Martin Griffin; Christophe Cellier; Georgia Malamut; Nadine Cerf-Bensussan; Martine Heyman
Journal:  Gastroenterology       Date:  2012-06-28       Impact factor: 22.682

8.  Renal involvement in cystic fibrosis: diseases spectrum and clinical relevance.

Authors:  Yasmina Yahiaoui; Mathieu Jablonski; Dominique Hubert; Helen Mosnier-Pudar; Laure-Hélène Noël; Marc Stern; Dominique Grenet; Jean-Pierre Grünfeld; Dominique Chauveau; Fadi Fakhouri
Journal:  Clin J Am Soc Nephrol       Date:  2009-04-30       Impact factor: 8.237

9.  Increased intestinal permeability to (51 Cr) EDTA is correlated with IgA immune complex-plasma levels in children with IgA-associated nephropathies.

Authors:  J C Davin; P Forget; P R Mahieu
Journal:  Acta Paediatr Scand       Date:  1988-01

Review 10.  Secondary IgA nephropathy.

Authors:  Shideh Pouria; Jonathan Barratt
Journal:  Semin Nephrol       Date:  2008-01       Impact factor: 5.299

View more
  41 in total

Review 1.  [Immunoglobulin A nephropathy].

Authors:  C Seikrit; T Rauen; J Floege
Journal:  Internist (Berl)       Date:  2019-05       Impact factor: 0.743

2.  Lysophosphatidic Acid Receptor 1 Is Important for Intestinal Epithelial Barrier Function and Susceptibility to Colitis.

Authors:  Songbai Lin; Yiran Han; Kayte Jenkin; Sei-Jung Lee; Maiko Sasaki; Jan-Michael Klapproth; Peijian He; C Chris Yun
Journal:  Am J Pathol       Date:  2017-11-09       Impact factor: 4.307

3.  Intrinsic renal cells induce lymphocytosis of Th22 cells from IgA nephropathy patients through B7-CTLA-4 and CCL-CCR pathways.

Authors:  Lu Gan; Qiaoling Zhou; Xiaozhao Li; Chen Chen; Ting Meng; Jiaxi Pu; Mengyuan Zhu; Chenggen Xiao
Journal:  Mol Cell Biochem       Date:  2017-09-05       Impact factor: 3.396

4.  Mannose-Binding Lectin Levels Could Predict Prognosis in IgA Nephropathy.

Authors:  Wei-Yi Guo; Li Zhu; Si-Jun Meng; Su-Fang Shi; Li-Jun Liu; Ji-Cheng Lv; Hong Zhang
Journal:  J Am Soc Nephrol       Date:  2017-07-11       Impact factor: 10.121

5.  Glomerular disease: Rituximab therapy for IgA nephropathy.

Authors:  Jürgen Floege
Journal:  Nat Rev Nephrol       Date:  2016-12-28       Impact factor: 28.314

6.  Tonsillitis exacerbates renal injury in IgA nephropathy through promoting Th22 cells chemotaxis.

Authors:  Lu Gan; Mengyuan Zhu; Xiaozhao Li; Chen Chen; Ting Meng; Jiaxi Pu; Huiming Luo; Fengmin Shao; Qiaoling Zhou
Journal:  Int Urol Nephrol       Date:  2018-03-16       Impact factor: 2.370

7.  Immunosuppressive therapy for active IgA nephropathy is effective and safe, even in "elderly" patients.

Authors:  Michio Fukuda; Osamu Hotta; Masashi Mizuno; Yoshiaki Ogiyama; Nobuyuki Ohte
Journal:  Clin Exp Nephrol       Date:  2016-07-21       Impact factor: 2.801

8.  TLR7 in B cells promotes renal inflammation and Gd-IgA1 synthesis in IgA nephropathy.

Authors:  Nuoyan Zheng; Kaifeng Xie; Hongjian Ye; Yu Dong; Bing Wang; Ning Luo; Jinjin Fan; Jiaqing Tan; Wei Chen; Xueqing Yu
Journal:  JCI Insight       Date:  2020-07-23

Review 9.  [What is certain in the treatment of glomerulonephritis?]

Authors:  J Floege; P Boor; M J Moeller
Journal:  Internist (Berl)       Date:  2018-12       Impact factor: 0.743

Review 10.  New therapeutic perspectives for IgA nephropathy in children.

Authors:  Alexandra Cambier; Patrick J Gleeson; Héloise Flament; Marie-Bénédicte Le Stang; Renato C Monteiro
Journal:  Pediatr Nephrol       Date:  2020-02-10       Impact factor: 3.714

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.